Clinical Trial Update: A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Upadacitinib in combination with topical corticosteroids for adolescents and adults with moderate-to-severe atopic dermatitis has pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-03-31